Commentary on "Use of pharmacodynamic endpoints for the evaluation of levofloxacin for the treatment of acute maxillary sinusitis" by Ambrose et al.
Gwaltney
Jack M
JM
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D064704:Levofloxacin; D015523:Maxillary Sinusitis / Q000188:drug therapy*; D015242:Ofloxacin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D064704:Levofloxacin; D015242:Ofloxacin